Mutant KRAS is a druggable target for pancreatic cancer
突变型 KRAS 是治疗胰腺癌的药物靶点
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:
doi:10.1073/pnas.1314307110
Elina Zorde Khvalevsky, Racheli Gabai, Itzhak Haim Rachmut, Elad Horwitz, Zivia Brunschwig, Ariel Orbach, Adva Shemi, Talia Golan, Abraham J Domb, Eylon Yavin, Hilla Giladi, Ludmila Rivkin, Alina Simerzin, Rami Eliakim, Abed Khalaileh, Ayala Hubert, Maor Lahav, Yael Kopelman, Eran Goldin, Alan Danco
